SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 21 - Sayı: 1

Non-ergot dopamine agonists and heart failure

Yusuf Ziya ŞENER
Metin OKŞUL
Cem ÇÖTELİ
Pages
53–53
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ŞENER, Y. Z., OKŞUL, M., ÇÖTELİ, C. (2019). Non-ergot dopamine agonists and heart failure. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 1, 53–53. https://ajindex.com/articles/365265

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Erken Pamukcu H, Gerede Uludağ DM, Tekin Tak B, Sorgun MH, Efe TH, Acıbuca A, et al. Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography. Anatol J Cardiol 2018; 20: 213-9
  2. De Vecchis R, Cantatrione C, Mazzei D, Baldi C, Di Maio M. NonErgot Dopamine Agonists Do Not Increase the Risk of Heart Failure in Parkinson's Disease Patients: A Meta-Analysis of Randomized Controlled Trials. J Clin Med Res 2016; 8: 449-60
  3. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al.; Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18: 891-975